European tech funding raised by Switzerland startups during H1 2014.
In H1 2014, 26 startups in Switzerland raised a combined €165M across 27 funding rounds, up 88.9% versus H1 2013. Healthtech was the most active sector, and Swisscom Ventures was the most active investor. Data as of 6 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| NovImmune | Series D+ | Feb 2014 | €49M |
| CRISPR Therapeutics | Series A | Apr 2014 | €23M |
| Silent Circle | Growth/Late | May 2014 | €22M |
| AC Immune | Series D+ |
| Jan 2014 |
| €18M |
| Sequana Medical | Series C | Apr 2014 | €17M |
| beqom | Debt | Apr 2014 | €7.7M |
| Aleva Neurotherapeutics | Series B | May 2014 | €5.8M |
| Nexthink | Growth/Late | Jun 2014 | €5.1M |
| Scandit | Early VC | Mar 2014 | €4.0M |
| ProteoMediX | Series B | Apr 2014 | €2.6M |
| Nanolive | Early VC | Apr 2014 | €2.5M |
| Tresorit | Series A | May 2014 | €2.2M |
| Biocartis | Grant | Jun 2014 | €1.7M |
| dizmo | Other | Jun 2014 | €1.5M |
| Endignorance | Seed | Jan 2014 | €885k |
